Irska - angleščina - HPRA (Health Products Regulatory Authority)

roche products (ireland) ltd - levodopa; benserazide - dispersible tablet - 100 mg/25 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

stada pharmaceuticals australia pty ltd - levodopa, quantity: 75 mg; carbidopa monohydrate, quantity: 20.25 mg (equivalent: carbidopa, qty 18.75 mg); entacapone, quantity: 200 mg - tablet, film coated - excipient ingredients: trehalose dihydrate; microcrystalline cellulose; carmellose sodium; hyprolose; sodium sulfate; magnesium stearate; powdered cellulose; titanium dioxide; iron oxide yellow; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - levodopa/carbidopa/entacapone is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.

Irska - angleščina - HPRA (Health Products Regulatory Authority)

roche products limited - levodopa benserazide hydrochloride - capsules hard - 100/25 milligram

Irska - angleščina - HPRA (Health Products Regulatory Authority)

roche products limited - levodopa benserazide hydrochloride - capsules hard - 50/12.5 milligram

Irska - angleščina - HPRA (Health Products Regulatory Authority)

roche products limited - levodopa benserazide hydrochloride - prolonged release capsules - 100/25 milligram

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - levodopa, quantity: 75 mg; carbidopa monohydrate, quantity: 20.25 mg (equivalent: carbidopa, qty 18.75 mg); entacapone, quantity: 200 mg - tablet, film coated - excipient ingredients: sodium sulfate; hyprolose; carmellose sodium; microcrystalline cellulose; magnesium stearate; trehalose dihydrate; powdered cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - levodopa/carbidopa/entacapone is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - levodopa, quantity: 200 mg; carbidopa monohydrate, quantity: 54 mg (equivalent: carbidopa, qty 50 mg); entacapone, quantity: 200 mg - tablet, film coated - excipient ingredients: powdered cellulose; microcrystalline cellulose; sodium sulfate; carmellose sodium; magnesium stearate; hyprolose; trehalose dihydrate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - levodopa/carbidopa/entacapone is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

roche sa-nv - levodopa 100 mg; benserazide hydrochloride 28,5 mg - eq. benserazide 25 mg - dispersible tablet - 100 mg - 25 mg - levodopa 100 mg; benserazide hydrochloride 28.5 mg - levodopa and decarboxylase inhibitor

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

roche sa-nv - levodopa 200 mg; benserazide hydrochloride 57 mg - eq. benserazide 50 mg - tablet - 200 mg - 50 mg - levodopa 200 mg; benserazide hydrochloride 57 mg - levodopa and decarboxylase inhibitor

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

roche sa-nv - levodopa 100 mg; benserazide hydrochloride 28,5 mg - eq. benserazide 25 mg - prolonged-release capsule, hard - 100 mg - 25 mg - levodopa 100 mg; benserazide hydrochloride 28.5 mg - levodopa and decarboxylase inhibitor